Nivolumab vs Rabeprazole

## Nivolumab vs Rabeprazole: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Rabeprazole**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Rabeprazole**: Proton pump inhibitor irreversibly inhibiting gastric H+/K+-ATPase with faster onset than omeprazole.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Rabeprazole — 1-2 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Rabeprazole — C18H21N3O3S.

**Molecular Weight**: Nivolumab — N/A; Rabeprazole — 359.4440 g/mol.

**Type**: Nivolumab — Antibody; Rabeprazole — Small molecule.